BIODIEM LIMITED (BDM)

BIODIEM LIMITED

ASX code: BDM
Listing Date: Wed, 28 Jan 2004
Website: http://www.biodiem.com/
Industry: Pharmaceuticals, Biotechnology & Life Sciences

Principal Activities:
Commercialisation of biotechnology research.

Address:
459 Collins Street, South Tower, Level 10
MELBOURNE
VIC    3000

Phone: (03) 9613 4100
Fax: (03) 9613 4111

Executives & Directors

Mr Hugh Morgan, Chairman, Director
Dr Andrew O'Brien, Executive Director, CEO
Mr Don Brooks, Non Exec. Director
Dr John Brown, Non Exec. Director
Prof. Larisa Rudenko, Non Exec. Director
Mr Richard Wadley, CFO

Please contact the ASX to change these details

Company Podcasts

Subscribe to current and future audio events for this company by clicking on the podcast icon:

Subscribe to BIODIEM LIMITED Podcasts

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

 

View this company's details on the Australian Securities Exchange website

BIODIEM LIMITED (BDM) Events

Company (Stock Code) Date/Time Event Timezone:
Icon_timezone Australia/NSW
Dr Andrew O'Brien Fri, 30 Nov 2007
04:45PM
BDM - 2007 Annual General Meeting Summary - Dr Andrew O'Brien, Managing Director Listen to this event
Add BIODIEM LIMITED to your alerts More Pharmaceuticals, Biotechnology & Life Sciences events Podcast of events for BIODIEM LIMITED
Dr. Andrew P. O’Brien Tue, 9 Oct 2007
04:30PM
BDM - Raised $7m in Placement - Dr. Andrew O’Brien, Managing Director Listen to this event
Add BIODIEM LIMITED to your alerts More Pharmaceuticals, Biotechnology & Life Sciences events Contact Dr. Andrew P. O’Brien Podcast of events for BIODIEM LIMITED
Mr Tom Williams Fri, 31 Aug 2007
02:00PM
BDM - FY07 Results and Commencement of 4 New Monash Studies for Eye Drug BMD-E - Mr Tom Williams, MD Listen to this event
Add BIODIEM LIMITED to your alerts More Pharmaceuticals, Biotechnology & Life Sciences events Contact Mr Tom Williams Podcast of events for BIODIEM LIMITED
Mr Tom Williams Mon, 13 Aug 2007
05:00PM
BDM - Completes Treatment Phase I and II Study of Eye Drug - Mr Tom Williams, MD Listen to this event
Add BIODIEM LIMITED to your alerts More Pharmaceuticals, Biotechnology & Life Sciences events Contact Mr Tom Williams Podcast of events for BIODIEM LIMITED
Wed, 26 Nov 2008
03:00PM
03:00PM Australia/Victoria
Annual General Meeting
The Sebel, 394 Collins St, Melbourne, VIC
Fri, 29 Aug 2008 Full Year Results
Tue, 26 Feb 2008 Interim Results
Fri, 30 Nov 2007
12:00PM
12:00PM Australia/Victoria
Annual General Meeting
Cliftons, Level 2, 440 Collins Street, Melbourne, Victoria, 3000
Thu, 30 Aug 2007 Full Year Results
Wed, 21 Feb 2007 Interim Results
Fri, 27 Oct 2006
04:00PM
Annual General Meeting
LaTrobe Room, The Rialto Hotel on Collins, 495 Collins Street Melbourne VIC 3000
Wed, 30 Aug 2006 Full Year Results
Wed, 1 Mar 2006 Interim Results
Fri, 28 Oct 2005
04:00PM
Annual General Meeting
 

BIODIEM LIMITED (BDM)

Appendix 4C - quarterly Fri, 31 Oct 2008
Notice of Annual General Meeting/Proxy Form Fri, 24 Oct 2008
Annual Report to shareholders Fri, 24 Oct 2008
Extension of Co-operative Research and Development Agreement Mon, 20 Oct 2008
Change in substantial holding Wed, 24 Sep 2008
LAIV data presented at 3rd European Influenza Conference Tue, 16 Sep 2008
Commentary Full Year Results Fri, 29 Aug 2008
Full Year Statutory Accounts Fri, 29 Aug 2008
Preliminary Final Report Fri, 29 Aug 2008
BDM announces development of protocol for BDM E manufacture Wed, 20 Aug 2008

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.

Register for Boardroom Radio Alerts

Receive email alerts when companies
you are interested in broadcast events.

Already registered?
Manage your alerts here